BGB-8035

• Description:

  BGB-8035 is an orally available, selective and potent BTK inhibitor with antitumor activity that inhibits BTK, TEC and EGFR.BGB-8035 is used in the study of tumors and autoimmune diseases.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  453.53

• Molecular Formula:

  C24H31N5O4

• Notes:

  Research use only, not for human use.

• Receptor:

  BTK | EGFR

• CAS Number:

  2283349-24-4